Cleared Traditional

K083313 - WILDCAT 7F GUIDEWIRE SUPPORT CATHETER

K083313 is the FDA 510(k) clearance for WILDCAT 7F GUIDEWIRE SUPPORT CATHETER by Avinger, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K083313 · Avinger, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2009
Decision
84d
Days
Class 2
Risk

K083313 is an FDA 510(k) clearance for the WILDCAT 7F GUIDEWIRE SUPPORT CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Avinger, Inc. (Redwood City, US). The FDA issued a Cleared decision on February 2, 2009 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Avinger, Inc. devices

Submission Details

510(k) Number K083313 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 10, 2008
Decision Date February 02, 2009
Days to Decision 84 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 125d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 574
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K083313.
ATTAIN COMMAND 6250 LEFT HEART DELIVERY SYSTEMS AND GUIDE CATHETERS FOR LEFT HEART DELIVERY
K090659 · Medtronic, Inc. · Mar 2009
6F TAIGA GUIDING CATHETER
K083422 · Medtronic Vascular · Feb 2009
ASAHI CORSAIR MICROCATHETER
K083127 · Asahi Intecc Co., Ltd. · Feb 2009
MINNIE SUPPORT CATHETER
K082337 · Vascular Solutions, Inc. · Jan 2009
CONQUEST PTA BALLOON DILATATION CATHETER
K083657 · C.R. Bard, Inc. · Dec 2008
CPS AIM SL SLITTABLE INNER CATHETER
K082932 · St Jude Medical · Dec 2008